Cytokinetics, Incorporated (CYTK) NASDAQ

48.44

+1.4(+2.98%)

Updated at January 02 09:54AM

Currency In USD

Valuation

Market Cap8.06B
Enterprise Value8.7B
P/E Ratio-9.6
PEG Ratio51.57
Price/Sales Ratio1,724.57
Price/Book Ratio-397.95
Enterprise/Revenue1,955.3
Enterprise/EBITDA-13

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-179.06
Operating Margin-162.98

Management Effectiveness

Return On Assets-0.4
Return On Equity3.35

Income Statement

Revenue7.53M
Revenue/Share0.03
Gross Profit-322.59M
EBITDA-456.68M
Net Income-526.24M
Diluted EPS-5.45

Balance Sheet

Total Cash1.01B
Total Cash/Share8.6
Total Debt789.63M
Total Debt/Equity-48.51
Current Ratio9.28
Book Value Per Share-0.12

Price History

52-Week Change-44.08
52-Week High110.25
52-Week Low45.66
Moving Average 50 Days51.35
Moving Average 200 Days56.63

Statistics

Average Volume1.17M
Shares Outstanding118.01M
% Held by Institutions114.84

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:6
Last Split DateJune 25, 2013